Published in
Elsevier, The Lancet Oncology, 12(18), p. 1590-1599, 2017
DOI: 10.1016/s1470-2045(17)30680-0
Links
Tools
Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial
Journal article published in 2017 by
Alice T. Shaw,
Enriqueta Felip,
Todd M. Bauer 
,
Benjamin Besse,
Alejandro Navarro,
Sophie Postel-Vinay,
Justin F. Gainor,
Melissa Johnson,
Jorg Dietrich,
Leonard P. James,
Jill S. Clancy,
Joseph Chen,
Jean-François Martini,
Antonello Abbattista,
Benjamin J. Solomon
,
Benjamin Besse,
Alejandro Navarro,
Sophie Postel-Vinay,
Justin F. Gainor,
Melissa Johnson,
Jorg Dietrich,
Leonard P. James,
Jill S. Clancy,
Joseph Chen,
Jean-François Martini,
Antonello Abbattista,
Benjamin J. Solomon
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 